| Company Name: |
BOC Sciences |
| Tel: |
1-631-485-4226; 16314854226 |
| Email: |
info@bocsci.com |
1,5-Bis[(E)-2-(3,4-dichlorophenyl)vinyl]-2,4-dinitrobenzene manufacturers
- NSC-636819
-
- $2520.00
-
2026-05-11
- CAS:1618672-71-1
- Purity: 98.00%
- Supply Ability: 10g
|
| | 1,5-Bis[(E)-2-(3,4-dichlorophenyl)vinyl]-2,4-dinitrobenzene Basic information |
| Product Name: | 1,5-Bis[(E)-2-(3,4-dichlorophenyl)vinyl]-2,4-dinitrobenzene | | Synonyms: | 1,5-Bis[(E)-2-(3,4-dichlorophenyl)vinyl]-2,4-dinitrobenzene;1,5-Bis[(1E)-2-(3,4-dichlorophenyl)ethenyl]-2,4-dinitrobenzene;NSC 636819;Benzene, 1,5-bis[(1E)-2-(3,4-dichlorophenyl)ethenyl]-2,4-dinitro-;KDM4A/KDM4B Inhibitor, NSC636819 | | CAS: | 1618672-71-1 | | MF: | C22H12Cl4N2O4 | | MW: | 510.15 | | EINECS: | | | Product Categories: | | | Mol File: | 1618672-71-1.mol | ![1,5-Bis[(E)-2-(3,4-dichlorophenyl)vinyl]-2,4-dinitrobenzene Structure](CAS/20180601/GIF/1618672-71-1.gif) |
| | 1,5-Bis[(E)-2-(3,4-dichlorophenyl)vinyl]-2,4-dinitrobenzene Chemical Properties |
| Boiling point | 625.5±55.0 °C(Predicted) | | density | 1.558±0.06 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | Soluble in DMSO | | form | Solid | | color | Yellow to orange |
| WGK Germany | WGK 3 | | Storage Class | 11 - Combustible Solids |
| | 1,5-Bis[(E)-2-(3,4-dichlorophenyl)vinyl]-2,4-dinitrobenzene Usage And Synthesis |
| Uses | NSC 636819 is a novel and selective KDM4A/KDM4B inhibitor that induces apoptosis in cultured prostate cancer cells. | | Biological Activity | Cell permeable: yes', 'Primary Target KDM4A/B', 'Reversible: yes | | in vivo | NSC636819 (C-4) (20 or 40 mg/kg; ip; 5 times a week; 4 weeks) strongly suppresses A549 tumor growth and sensitizes tumors to TRAIL-inducer ONC201 in mouse model[2]. | Animal Model: | A549 Lung cancer xenograft model in mice[2] | | Dosage: | 20 mg/kg, 40 mg/kg | | Administration: | ip; 5 times per weeks, 27 days; with or without ONC201 (i.p.; 25mg/kg, 1 time a week). | | Result: | Dose-dependently inhibited the tumor growth, and sensitized tumors to TRAIL. Induced tumor expression of TRAIL, DR5 and the level of cleaved caspase-7 and H3K9me3, whereas decreased the expression of KDM4A in xenograft tumors.
|
| | IC 50 | KDM4 | | storage | Store at +4°C |
| | 1,5-Bis[(E)-2-(3,4-dichlorophenyl)vinyl]-2,4-dinitrobenzene Preparation Products And Raw materials |
|